Sawai Group Holdings Co., Ltd.
Ticker
4887.T
ISIN
JP332304000
Price
JPY 1,974.50
Change Today
+27.50 / 1.412 %
Price 1 year ago
1,499.08 / 31.714 %
Market Capitalization
175,174,402,048.00
52 Week Low
1,508.10
52 Week High
2,193.04
200 Day Moving Average
1,955.36
50-day Moving Average
2,018.27
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. It offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, urogenital organs and the anus, antineoplastic, vitamins, anti-cancer, chemotherapeutic agents, respiratory organ agents, hormone agents, etc. The company's products include atorvastatin, limaprost alfadex, lansoprazole, aprepitant, micafungin sodium, silodosin, blonanserin, oseltamivir, capecitabine, atomoxetine hydrochloride, nalfurafine, memantine hydrochloride, eldecalcitol, bazedoxifene, fexofenadine hydrochloride, dutasteride, pregabalin, duloxetine hydrochloride, morphine sulfate tablets, tosymra nasal spray, zembrace symtouch, and ramelteon tablets. It also manufactures and sells medicinal products. The company sells its generic drugs to distributors, retail stores, and other pharmaceutical manufacturers, as well as directly to medical institutions, such as hospitals, general practitioners, and dispensing pharmacies in Japan; and pharmaceutical products to wholesalers in the United States. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
Japan
Exchange
JPX
Earnings Per Share
441.464
P/E Ratio
9.060761
Debt/Equity Ratio
29.463
Beta
-
Ebitda
40,526,999,552.00
-
Enterprise to Ebitda
5.50
Enterprise Value
222,871,486,464.00
Target Price
4,615.00
Estimated Price
-
Book Value
4,952.37
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
| Company | Name | Correlation |
|---|---|---|
| 600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | -0.80 |
| 300039.SZ | SHANGHAI KAIBAO PH | -0.69 |
| 600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | -0.64 |
| 300199.SZ | HYBIO PHARMACEUTIC | -0.61 |
| 600277.SS | ELION CLEAN ENERGY CO LTD | -0.52 |
| SIDO.JK | Industri Jamu dan Farmasi Sido | -0.46 |
| 600380.SS | JOINCARE PHARMACEUTICAL GROUP I | -0.42 |
| 300239.SZ | BAOTOU DONGBAO BIO | -0.35 |
| 300026.SZ | TIANJIN CHASE SUN | -0.34 |
| 300534.SZ | GANSU LONGSHENRONG | -0.33 |
| 300158.SZ | SHANXI ZHENDONG PH | -0.18 |
| 600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | -0.16 |
| HLN.L | HALEON PLC | -0.16 |
| 0460.HK | SIHUAN PHARM | -0.09 |
| 300110.SZ | HUAREN PHARMACEUTI | 0.07 |
| 0570.HK | TRAD CHI MED | 0.11 |
| 300142.SZ | WALVAX BIOTECHNOLO | 0.16 |
| 600518.SS | KANGMEI PHARMACEUTICAL CO LTD | 0.23 |
| 300194.SZ | FUAN PHARMACEUTICA | 0.23 |
| TEVA | Teva Pharmaceutical Industries | 0.23 |
| 600216.SS | ZHEJIANG MEDICINE | 0.25 |
| 600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | 0.35 |
| 600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | 0.36 |
| MCOA | MARIJUANA COMPANY OF AMERICA IN | 0.50 |
| 002001.SZ | ZHEJIANG NHU CO | 0.56 |
| SFLM | SFLMAVEN CORP | 0.59 |
| TLRY | Tilray Brands, Inc. - Class 2 | 0.60 |
| 600781.SS | FUREN GROUP PHARMACEUTICAL CO L | 0.75 |
Similar companies
| Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
|---|---|---|---|---|---|---|---|---|---|
| MCOA | MARIJUANA COMPANY OF AMERICA IN | Los Angeles | United States | USD | PNK | 1.15 | -1.91 | 7 | https://www.marijuanacompanyofamerica.com |
| 600277.SS | ELION CLEAN ENERGY CO LTD | Beijing | China | CNY | SHH | 0.81 | 14.08 | 3926 | https://www.elion.cn |
| 300026.SZ | TIANJIN CHASE SUN | Tianjin | China | CNY | SHZ | -0.10 | 16.16 | https://www.chasesun.cn | |
| ENDP | Endo International plc | Dublin | Ireland | USD | NMS | 1.12 | 9.59 | 3103 | https://www.endo.com |
| 300110.SZ | HUAREN PHARMACEUTI | Qingdao | China | CNY | SHZ | 0.86 | 22.14 | 2242 | https://www.qdhuaren.com |
| 600518.SS | KANGMEI PHARMACEUTICAL CO LTD | Puning | China | CNY | SHH | 0.26 | -11.18 | 6410 | https://www.kangmei.com.cn |
| 600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | Beijing | China | CNY | SHH | -0.16 | 12.21 | 11029 | https://www.dcpc.com |
| 600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | Wuhan | China | CNY | SHH | 0.87 | 13.32 | 15746 | https://www.humanwell.com.cn |
| SIDO.JK | Industri Jamu dan Farmasi Sido | Semarang | Indonesia | IDR | JKT | 0.14 | 15.04 | 3081 | https://www.sidomuncul.co.id |
| 600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | Shanghai | China | CNY | SHH | 0.65 | 30.59 | 36279 | https://www.fosunpharma.com |
| HLN.L | HALEON PLC | Weybridge | United Kingdom | GBp | LSE | 16.31 | 22000 | https://www.haleon.com | |
| 002001.SZ | ZHEJIANG NHU CO | Xinchang | China | CNY | SHZ | 0.31 | 10.45 | 10805 | https://www.cnhu.com |
| 0460.HK | SIHUAN PHARM | Wan Chai | Hong Kong | HKD | HKG | 0.61 | 7.15 | 4282 | https://www.sihuanpharm.com |
| TLRY | Tilray Brands, Inc. - Class 2 | Leamington | Canada | USD | NMS | -28.58 | https://www.tilray.com | ||
| 300199.SZ | HYBIO PHARMACEUTIC | Shenzhen | China | CNY | SHZ | 0.02 | -117.98 | 885 | https://www.hybio.com.cn |
| 0570.HK | TRAD CHI MED | Wan Chai | Hong Kong | HKD | HKG | 0.51 | 5.97 | 17098 | https://www.china-tcm.com.cn |
| 600216.SS | ZHEJIANG MEDICINE | Shaoxing | China | CNY | SHH | -0.16 | 7.75 | 5901 | https://www.zmc.top |
| 300194.SZ | FUAN PHARMACEUTICA | Chongqing | China | CNY | SHZ | 0.41 | 15.82 | 3004 | https://www.fapharm.com |
| 300039.SZ | SHANGHAI KAIBAO PH | Shanghai | China | CNY | SHZ | 0.31 | 32.28 | 1432 | https://www.xykb.com |
| 300142.SZ | WALVAX BIOTECHNOLO | Kunming | China | CNY | SHZ | 0.62 | 56.64 | https://www.walvax.com | |
| 300239.SZ | BAOTOU DONGBAO BIO | Baotou | China | CNY | SHZ | 0.26 | 43.88 | 1354 | https://www.dongbaoshengwu.com |
| 600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | Wuzhou | China | CNY | SHH | 0.39 | 56.88 | 3453 | https://www.wz-zhongheng.com |
| 300158.SZ | SHANXI ZHENDONG PH | Changzhi | China | CNY | SHZ | 0.32 | 5.06 | 4123 | https://www.zdjt.com |
| 600781.SS | FUREN GROUP PHARMACEUTICAL CO L | Shanghai | China | CNY | SHH | 0.27 | -5.14 | 2916 | https://www.shfuren.cn |
| ZOM | Zomedica Corp. | Ann Arbor | United States | USD | ASE | 0.59 | -3.10 | 47 | https://www.zomedica.com |
| 300534.SZ | GANSU LONGSHENRONG | Lanzhou | China | CNY | SHZ | 0.38 | 195.38 | 302 | https://www.lsrfzy.com |
| SFLM | SFLMAVEN CORP | Leamington Spa | United Kingdom | USD | PNK | 3.15 | -1.48 | 1 | https://www.dnadynamicsinc.com |
| 600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | Nanchang | China | CNY | SHH | 0.40 | 9.25 | 4153 | https://www.jzjt.com |
| 600380.SS | JOINCARE PHARMACEUTICAL GROUP I | Shenzhen | China | CNY | SHH | 0.66 | 6.07 | 13234 | https://www.joincare.com |
| TEVA | Teva Pharmaceutical Industries | Tel Aviv | Israel | USD | NYQ | 1.22 | 7.45 | 34713 | https://www.tevapharm.com |
| 600521.SS | ZHEJIANG HUAHAI PHARMACEUTICAL | Linhai | China | CNY | SHH | 0.22 | 30.80 | 7019 | https://www.huahaipharm.com |
| 600664.SS | HARBIN PHARMACEUTICAL GROUP CO | Harbin | China | CNY | SHH | 9.55 | https://www.hayao.com | ||
| 300401.SZ | ZHEJIANG GARDEN BI | Dongyang | China | CNY | SHZ | -0.24 | 14.95 | 742 | https://www.hybiotech.com |
| 600568.SS | ZHONG ZHU HEALTHCARE HOLDING CO | Zhuhai | China | CNY | SHH | 0.45 | -231.66 | 1286 | https://www.zz600568.com |
| CGC | Canopy Growth Corporation | Smiths Falls | Canada | USD | NMS | 2.23 | -2.61 | 3151 | https://www.canopygrowth.com |
| DVLP | GOLDEN DEVELOPING SOLUTIONS INC | Fort Lauderdale | United States | USD | PNK | 1.60 | https://goldendeveloping.com | ||
| SIGA | SIGA Technologies Inc. | New York | United States | USD | NGM | 0.40 | 12.13 | 39 | https://www.siga.com |
| 3320.HK | CHINARES PHARMA | Wan Chai | Hong Kong | HKD | HKG | 0.42 | 9.52 | 65000 | https://www.crpharm.com |
| 300601.SZ | SHENZHEN KANGTAI B | Shenzhen | China | CNY | SHZ | 0.31 | 17.71 | 2445 | https://www.biokangtai.com |
| 600267.SS | ZHEJIANG HISUN PHARMACEUTICAL C | Taizhou | China | CNY | SHH | 0.53 | 11.17 | 8280 | https://www.hisunpharm.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.